Global Healthcare Biometrics Market Set To Grow To $5.02 In 2023

02 August 2018
Pharma

Visiongain has launched a new pharma report Global Healthcare Biometrics Market Forecast 2018-2028: Patient Identification & Tracking, Care Provider Authentication, Medical Record Security & Data Centre Security, Remote Patient Monitoring, Pharmacy Dispensing, Face Recognition, Finger Recognition, Iris Recognition, Vein Recognition, Palm Geometry Recognition, Behavioural Recognition, Hospitals & Clinics, Research & Clinical Laboratory

The biometric technologies including fingerprint recognition, vein recognition, iris recognition, and face recognition are gaining popularity in healthcare sector. The rise in popularity is due to its wide range of applications for health-care provider authentication, patient identification and tracking, medical record security, and data centre security. The growing demand for these biometrics solutions is primarily driven by the need to improve patient confidentiality, and healthcare safety.

In the recent past there has been an increase in the adoption of biometric in the healthcare industry. This integration majorly refers to patient identification and staff authentication. Healthcare industry in the United States is one of the most lucrative industries globally with over 17.9 percent of its Gross Domestic Product being spent on healthcare. According to World Health Organization, U.S. healthcare spending reached USD 2.9 trillion in the year 2013. These facts are indicative of the immense burden healthcare providers’ face on a daily basis to treat patients with a wide range of disorders.

‘’Global healthcare biometrics market is growing rapidly, this is primarily due to increasing awareness about safety and security of patients, increasing application of biometrics devices in healthcare sector application and other data and growing healthcare infrastructure. North America accounts for largest market for healthcare biometrics devices while Asia-Pacific is fastest growing market. Global healthcare biometrics market is expected to grow to $5.02 billion by 2023.’’ – Pharmaceutical Industry Analyst

Leading companies featured in the report include Fujitsi Limited, 3M Congent, Inc.,NEC Corporation, Safran Identity & Security SAS (Morpho), Bio-Key International, Inc., Assa Abloy Group, Imprivata, Inc., Suprema, Inc, Crossmatch Technologies, Inc., Zkteco, Inc.

Notes for Editors
If you are interested in a more detailed overview of this report, please send an e-mail to sara.peerun@visiongainglobal.com or call her on +44 (0) 207 336 6100

About visiongain
Visiongain is one of the fastest-growing and most innovative independent media companies in Europe. Based in London, UK, visiongain produces a host of business-to-business reports cusing on the automotive, aviation, chemicals, cyber, defence, energy, food & drink, materials, packaging, pharmaceutical and utilities sectors.

Visiongain publishes reports produced by analysts who are qualified experts in their field. Visiongain has firmly established itself as the first port of call for the business professional who needs independent, high-quality, original material to rely and depend on.

Recent News

“Oncology remains the largest disease area in the pharmaceutical business. The oncology market is dominated by big pharma companies and high price labels” says Visiongain report

Although price is still the most important competitive advantage for a biosimilar company, current discount rates are not enough to automatically convince the key stakeholders of a biosimilar’s value.

10 September 2019

Read

“Anti-Infective Agents market set to grow to $141bn by 2024” says new Visiongain report

The global anti-infective agents market is one that is driven by innovation. This is vital for maintaining the rich pipeline of anti-infective agents seen in the market today.

09 September 2019

Read

“Global thyroid gland disorder treatment market is anticipated to grow at a lucrative CAGR of 3.6% and anticipated to reach USD 3.21 Billion by 2029”, says Visiongain report.

Thyroid disease is one of today’s most prevalent hormonal illnesses. Hyperthyroidism, hypothyroidism, and thyroid nodules are the most common thyroid gland disorders.

05 September 2019

Read

“Global somatostatin analogs market is anticipated to grow at a lucrative CAGR of 5.3% and anticipated to reach USD 4.78 Bn by 2029”, says Visiongain report.

Somatostatin was used to diagnose gastrointestinal tract tumors and acromegaly in the clinical environment.

05 September 2019

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever